Related references
Note: Only part of the references are listed.'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media
Matthew Bauler et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
N. N. Parayath et al.
NATURE COMMUNICATIONS (2020)
Entering the Modern Era of Gene Therapy
Xavier M. Anguela et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Manufacturing chimeric antigen receptor T cells: issues and challenges
Claire Roddie et al.
CYTOTHERAPY (2019)
How mRNA therapeutics are entering the monoclonal antibody field
Lien Van Hoecke et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Highly Efficient and Selective CAR-Gene Transfer Using CD4-and CD8-Targeted Lentiviral Vectors
Arezoo Jamali et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: Drug Products, Including Biological Products, that Contain Nanomaterials
Jon S. B. de Vlieger et al.
AAPS JOURNAL (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Critical process parameters in manufacturing of liposomal formulations of amphotericin B
Benjamin Rivnay et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Gene editing for immune cell therapies
Stefanie R. Bailey et al.
NATURE BIOTECHNOLOGY (2019)
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G. Chapuis et al.
NATURE MEDICINE (2019)
Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA
Stuart M. Ellison et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
Melissa P. Lokugamage et al.
ADVANCED MATERIALS (2019)
The Development of Functional Non-Viral Vectors for Gene Delivery
Suryaji Patil et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Allogeneic CAR T cell therapies for leukemia
Waseem Qasim
AMERICAN JOURNAL OF HEMATOLOGY (2019)
In vivo generated human CAR T cells eradicate tumor cells
Shiwani Agarwal et al.
ONCOIMMUNOLOGY (2019)
Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles
Yu-Sang Sabrina Yang et al.
BIOMATERIALS SCIENCE (2019)
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Stephan Kloess et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Development of a novel one-step production system for injectable liposomes under GMP
Ryo Araki et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2018)
Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line
Diogo Gomes-Silva et al.
BIOTECHNOLOGY JOURNAL (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Gregory L. Beatty et al.
GASTROENTEROLOGY (2018)
Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene
Weihua Yuan et al.
JOURNAL OF GENE MEDICINE (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi et al.
CANCER IMMUNOLOGY RESEARCH (2018)
In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome
Anett Pfeiffer et al.
EMBO MOLECULAR MEDICINE (2018)
A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles
Maria Camilla Operti et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Ruchi Jain et al.
NUCLEIC ACID THERAPEUTICS (2018)
Genetic variants associated with colorectal brain metastases susceptibility and survival
S. Stremitzer et al.
PHARMACOGENOMICS JOURNAL (2017)
Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
R. Monjezi et al.
LEUKEMIA (2017)
Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
Arnab Ghosh et al.
NATURE MEDICINE (2017)
Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids
Christopher S. Seet et al.
NATURE METHODS (2017)
Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1
Shreya Shukla et al.
NATURE METHODS (2017)
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Tyrel T. Smith et al.
NATURE NANOTECHNOLOGY (2017)
Isolation of isoform-specific binding proteins (Affimers) by phage display using negative selection
Anna Ah-San Tang et al.
SCIENCE SIGNALING (2017)
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
H. F. Moffett et al.
NATURE COMMUNICATIONS (2017)
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid et al.
NATURE COMMUNICATIONS (2017)
A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies
Michael White et al.
HUMAN GENE THERAPY METHODS (2017)
Isolation of isoform-specific binding proteins (Affimers) by phage display using negative selection
Anna Ah-San Tang et al.
SCIENCE SIGNALING (2017)
Synthetic mRNA capping
Fabian Muttach et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2017)
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy
Michela Milani et al.
EMBO MOLECULAR MEDICINE (2017)
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
Xiuli Wang et al.
BLOOD (2016)
Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study
Sharon H. Giordano et al.
CANCER (2016)
Putting a price tag on novel autologous cellular therapies
Mohamed Abou-El-Enein et al.
CYTOTHERAPY (2016)
Challenges of up-scaling lentivirus production and processing
Alexandra McCarron et al.
JOURNAL OF BIOTECHNOLOGY (2016)
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response
Richard P. Junghans et al.
PROSTATE (2016)
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
Srinivas Ramishetti et al.
ACS NANO (2015)
Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo
Antonella Mangraviti et al.
ACS NANO (2015)
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells
Julia A. M. Sung et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Redirection of CD4+and CD8+T lymphocytes via an anti-CD3 x anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells
Dongmei Fan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors
Qi Zhou et al.
JOURNAL OF IMMUNOLOGY (2015)
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Max S. Topp et al.
LANCET ONCOLOGY (2015)
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells
Shigeki Yagyu et al.
MOLECULAR THERAPY (2015)
Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo
Alessandra Quarta et al.
NANOSCALE (2015)
Outcomes of the ACT III Study: Rindopepimut (CDX-110) Therapy for Glioblastoma
Benjamin M. Zussman et al.
NEUROSURGERY (2015)
In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells
Luca Biasco et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Are BiTEs the missing link in cancer therapy?
Carter M. Suryadevara et al.
ONCOIMMUNOLOGY (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Gene Therapy for Wiskott-Aldrich Syndrome-Long-Term Efficacy and Genotoxicity
Christian Joerg Braun et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A. Sheikh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
Maria Themeli et al.
NATURE BIOTECHNOLOGY (2013)
Relapse of melanoma after successful adoptive T-cell therapy: escape through inflammation-induced phenotypic melanoma cell plasticity
Rajasekharan Somasundaram et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Production and Characterization of Novel Recombinant Adeno-Associated Virus Replicative-Form Genomes: A Eukaryotic Source of DNA for Gene Transfer
Lina Li et al.
PLOS ONE (2013)
Thinking continuously: a microreactor for the production and scale-up of biodegradable, self-assembled nanoparticles
Christina Petschacher et al.
POLYMER CHEMISTRY (2013)
Immune responses in liver-directed lentiviral gene therapy
Andrea Annoni et al.
TRANSLATIONAL RESEARCH (2013)
Nanoparticulate Nonviral Agent for the Effective Delivery of pDNA and siRNA to Differentiated Cells and Primary Human T Lymphocytes
Anja Schallon et al.
BIOMACROMOLECULES (2012)
T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing
Qi Zhou et al.
BLOOD (2012)
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants
Karen M. Kaluza et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA Transposon
Erin R. Burnight et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Matthias T. Stephan et al.
NANO TODAY (2011)
Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know
Steven A. Rosenberg
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Impact of Ex Vivo Clinical Grade Activation Protocols on Human T-cell Phenotype and Function for the Generation of Genetically Modified Cells for Adoptive Cell Transfer Therapy
Paul C. Tumeh et al.
JOURNAL OF IMMUNOTHERAPY (2010)
HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7
Karine Breckpot et al.
JOURNAL OF VIROLOGY (2010)
MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression
Chen Guihua et al.
BIOMATERIALS (2009)
Porous Nanoparticle Supported Lipid Bilayers (Protocells) as Delivery Vehicles
Juewen Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Greg M. Thurber et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Strategies for Targeting Lentiviral Vectors
Cecilia Frecha et al.
CURRENT GENE THERAPY (2008)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner
Subba Rao Nallagatla et al.
RNA (2008)
CD4-specific Designed Ankyrin Repeat Proteins are novel potent HIV entry inhibitors with unique characteristics
Andreas Schweizer et al.
PLOS PATHOGENS (2008)
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques
Hannah Yuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Efficiency of human immunodeficiency virus type 1 postentry infection processes: Evidence against disproportionate numbers of defective virions
James A. Thomas et al.
JOURNAL OF VIROLOGY (2007)
A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells
Tarek M. Fahmy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Nanosystems for simultaneous Imaging and drug delivery to T cells
Tarek M. Fahmy et al.
AAPS JOURNAL (2007)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Cotransduction of nondividing cells using lentiviral vectors
K Frimpong et al.
GENE THERAPY (2000)
VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum
NJ DePolo et al.
MOLECULAR THERAPY (2000)
Share Paper
